{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:02:22Z","timestamp":1787889742667,"version":"build-2784847793"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS099328"],"award-info":[{"award-number":["NS099328"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS083845"],"award-info":[{"award-number":["NS083845"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00018-024-05373-2","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T19:47:25Z","timestamp":1724183245000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["RXR nuclear receptor signaling modulates lipid metabolism and triggers lysosomal clearance of alpha-synuclein in neuronal models of synucleinopathy"],"prefix":"10.1007","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0108-2223","authenticated-orcid":false,"given":"Arati","family":"Tripathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Alnakhala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Brontesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Selkoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Dettmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"issue":"6645","key":"5373_CR1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388(6645):839\u2013840","journal-title":"Nature"},{"key":"5373_CR2","unstructured":"Parkinson\u2019s Foundation. https:\/\/www.parkinson.org\/understanding-parkinsons\/statistics Accessed 23 September 2023."},{"key":"5373_CR3","doi-asserted-by":"crossref","unstructured":"Parkinson J (2002) An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci 14(2):223\u201336; discussion 222.","DOI":"10.1176\/appi.neuropsych.14.2.223"},{"issue":"12","key":"5373_CR4","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D et al (2019) Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol 18(12):1091\u20131102","journal-title":"Lancet Neurol"},{"issue":"9","key":"5373_CR5","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/mds.25469","volume":"28","author":"K Brockmann","year":"2013","unstructured":"Brockmann K, Schulte C, Hauser AK, Lichtner P, Huber H, Maetzler W et al (2013) SNCA: major genetic modifier of age at onset of Parkinson\u2019s disease. Mov Disord Off J Mov Disord Soc 28(9):1217\u20131221","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"2","key":"5373_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1469-1809.2009.00560.x","volume":"74","author":"TL Edwards","year":"2010","unstructured":"Edwards TL, Scott WK, Almonte C, Burt A, Powell EH, Beecham GW et al (2010) Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet 74(2):97\u2013109","journal-title":"Ann Hum Genet"},{"issue":"5321","key":"5373_CR7","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276(5321):2045\u20132047","journal-title":"Science"},{"issue":"2","key":"5373_CR8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kr\u00fcger","year":"1998","unstructured":"Kr\u00fcger R, Kuhn W, M\u00fcller T, Woitalla D, Graeber M, K\u00f6sel S et al (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat Genet 18(2):106\u2013108","journal-title":"Nat Genet"},{"issue":"2","key":"5373_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, G\u00f3mez-Esteban JC, Lezcano E, Ros R, Ampuero I et al (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55(2):164\u2013173","journal-title":"Ann Neurol"},{"key":"5373_CR10","doi-asserted-by":"crossref","unstructured":"Appel-Cresswell S, Vilarino-Guell C, Encarnacion M, Sherman H, Yu I, Shah B, et al (2013) Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson\u2019s disease. Mov Disord Off J Mov Disord Soc 28(6):811\u2013813","DOI":"10.1002\/mds.25421"},{"issue":"4","key":"5373_CR11","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/ana.23894","volume":"73","author":"S Lesage","year":"2013","unstructured":"Lesage S, Anheim M, Letournel F, Bousset L, Honor\u00e9 A, Rozas N et al (2013) G51D \u03b1-synuclein mutation causes a novel parkinsonian-pyramidal syndrome. Ann Neurol 73(4):459\u2013471","journal-title":"Ann Neurol"},{"key":"5373_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13024-015-0038-3","volume":"10","author":"AP Kiely","year":"2015","unstructured":"Kiely AP, Ling H, Asi YT, Kara E, Proukakis C, Schapira AH et al (2015) Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation. Mol Neurodegener 10:41","journal-title":"Mol Neurodegener"},{"issue":"9","key":"5373_CR13","doi-asserted-by":"publisher","first-page":"2180.e1","DOI":"10.1016\/j.neurobiolaging.2014.03.024","volume":"35","author":"P Pasanen","year":"2014","unstructured":"Pasanen P, Myllykangas L, Siitonen M, Raunio A, Kaakkola S, Lyytinen J et al (2014) Novel \u03b1-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson\u2019s disease-type pathology. Neurobiol Aging 35(9):2180.e1\u20135","journal-title":"Neurobiol Aging"},{"key":"5373_CR14","doi-asserted-by":"crossref","unstructured":"Yoshino H, Hirano M, Stoessl AJ, Imamichi Y, Ikeda A, Li Y, et al (2017) Homozygous alpha-synuclein p.A53V in familial Parkinson\u2019s disease. Neurobiol Aging 57:248.e7\u2013248.e12.","DOI":"10.1016\/j.neurobiolaging.2017.05.022"},{"issue":"7","key":"5373_CR15","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/mds.28534","volume":"36","author":"H Liu","year":"2021","unstructured":"Liu H, Koros C, Stroh\u00e4ker T, Schulte C, Bozi M, Varvaresos S et al (2021) A novel SNCA A30G mutation causes familial Parkinson\u2019s disease. Mov Disord Off J Mov Disord Soc 36(7):1624\u20131633","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"5646","key":"5373_CR16","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J et al (2003) Alpha-Synuclein locus triplication causes Parkinson\u2019s disease. Science 302(5646):841","journal-title":"Science"},{"issue":"11","key":"5373_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026159","volume":"6","author":"B Byers","year":"2011","unstructured":"Byers B, Cord B, Nguyen HN, Sch\u00fcle B, Fenno L, Lee PC et al (2011) SNCA triplication Parkinson\u2019s patient\u2019s iPSC-derived DA neurons accumulate \u03b1-synuclein and are susceptible to oxidative stress. PLoS One 6(11):e26159","journal-title":"PLoS One"},{"key":"5373_CR18","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/ncomms1453","volume":"2","author":"MJ Devine","year":"2011","unstructured":"Devine MJ, Ryten M, Vodicka P, Thomson AJ, Burdon T, Houlden H et al (2011) Parkinson\u2019s disease induced pluripotent stem cells with triplication of the \u03b1-synuclein locus. Nat Commun 2:440","journal-title":"Nat Commun"},{"issue":"9440","key":"5373_CR19","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"MC Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S et al (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson\u2019s disease. Lancet Lond Engl 364(9440):1167\u20131169","journal-title":"Lancet Lond Engl"},{"key":"5373_CR20","doi-asserted-by":"crossref","unstructured":"Konno T, Ross OA, Puschmann A, Dickson DW, Wszolek ZK (2016) Autosomal dominant Parkinson\u2019s disease caused by SNCA duplications. Parkinsonism Relat Disord 22(Suppl 1):S1\u2013S6","DOI":"10.1016\/j.parkreldis.2015.09.007"},{"issue":"2","key":"5373_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41591-019-0739-1","volume":"26","author":"AH Laperle","year":"2020","unstructured":"Laperle AH, Sances S, Yucer N, Dardov VJ, Garcia VJ, Ho R et al (2020) iPSC modeling of young-onset Parkinson\u2019s disease reveals a molecular signature of disease and novel therapeutic candidates. Nat Med 26(2):289\u2013299","journal-title":"Nat Med"},{"issue":"2","key":"5373_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nm.4269","volume":"23","author":"YC Wong","year":"2017","unstructured":"Wong YC, Krainc D (2017) \u03b1-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies. Nat Med 23(2):1\u201313","journal-title":"Nat Med"},{"issue":"2","key":"5373_CR23","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis L (2012) \u03b1-Synuclein in Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2(2):a009399","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"5373_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/biom12010040","volume":"12","author":"A Tripathi","year":"2021","unstructured":"Tripathi A, Fanning S, Dettmer U (2021) Lipotoxicity downstream of \u03b1-synuclein imbalance: a relevant pathomechanism in synucleinopathies? Biomolecules 12(1):40","journal-title":"Biomolecules"},{"issue":"3","key":"5373_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00401-023-02601-0","volume":"146","author":"M Flores-Leon","year":"2023","unstructured":"Flores-Leon M, Outeiro TF (2023) More than meets the eye in Parkinson\u2019s disease and other synucleinopathies: from proteinopathy to lipidopathy. Acta Neuropathol (Berl) 146(3):369\u2013385","journal-title":"Acta Neuropathol (Berl)"},{"key":"5373_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41531-019-0103-7","volume":"6","author":"S Fanning","year":"2020","unstructured":"Fanning S, Selkoe D, Dettmer U (2020) Parkinson\u2019s disease: proteinopathy or lipidopathy? NPJ Park Dis 6:3","journal-title":"NPJ Park Dis"},{"issue":"7","key":"5373_CR27","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","volume":"22","author":"SH Shahmoradian","year":"2019","unstructured":"Shahmoradian SH, Lewis AJ, Genoud C, Hench J, Moors TE, Navarro PP et al (2019) Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes. Nat Neurosci 22(7):1099\u20131109","journal-title":"Nat Neurosci"},{"issue":"2","key":"5373_CR28","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1006\/exnr.2000.7527","volume":"166","author":"WP Gai","year":"2000","unstructured":"Gai WP, Yuan HX, Li XQ, Power JT, Blumbergs PC, Jensen PH (2000) In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies. Exp Neurol 166(2):324\u2013333","journal-title":"Exp Neurol"},{"key":"5373_CR29","doi-asserted-by":"publisher","first-page":"17625","DOI":"10.1038\/srep17625","volume":"5","author":"K Araki","year":"2015","unstructured":"Araki K, Yagi N, Ikemoto Y, Yagi H, Choong CJ, Hayakawa H et al (2015) Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson\u2019s disease patients. Sci Rep 5:17625","journal-title":"Sci Rep"},{"issue":"3","key":"5373_CR30","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00401-021-02329-9","volume":"142","author":"TE Moors","year":"2021","unstructured":"Moors TE, Maat CA, Niedieker D, Mona D, Petersen D, Timmermans-Huisman E et al (2021) The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson\u2019s disease brain as revealed by multicolor STED microscopy. Acta Neuropathol (Berl) 142(3):423\u2013448","journal-title":"Acta Neuropathol (Berl)"},{"issue":"4","key":"5373_CR31","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jmb.2009.05.066","volume":"390","author":"CR Bodner","year":"2009","unstructured":"Bodner CR, Dobson CM, Bax A (2009) Multiple tight phospholipid-binding modes of alpha-synuclein revealed by solution NMR spectroscopy. J Mol Biol. 390(4):775\u201390","journal-title":"J Mol Biol."},{"issue":"5","key":"5373_CR32","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1021\/bi901723p","volume":"49","author":"CR Bodner","year":"2010","unstructured":"Bodner CR, Maltsev AS, Dobson CM, Bax A (2010) Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson\u2019s disease revealed by solution NMR spectroscopy. Biochemistry 49(5):862\u2013871","journal-title":"Biochemistry"},{"issue":"4","key":"5373_CR33","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.plipres.2010.05.004","volume":"49","author":"V Ruip\u00e9rez","year":"2010","unstructured":"Ruip\u00e9rez V, Darios F, Davletov B (2010) Alpha-synuclein, lipids and Parkinson\u2019s disease. Prog Lipid Res 49(4):420\u2013428","journal-title":"Prog Lipid Res"},{"issue":"5","key":"5373_CR34","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.jmb.2007.11.051","volume":"375","author":"M St\u00f6ckl","year":"2008","unstructured":"St\u00f6ckl M, Fischer P, Wanker E, Herrmann A (2008) Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains. J Mol Biol 375(5):1394\u20131404","journal-title":"J Mol Biol"},{"issue":"16","key":"5373_CR35","doi-asserted-by":"publisher","first-page":"9110","DOI":"10.1073\/pnas.171300598","volume":"98","author":"R Sharon","year":"2001","unstructured":"Sharon R, Goldberg MS, Bar-Josef I, Betensky RA, Shen J, Selkoe DJ (2001) alpha-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins. Proc Natl Acad Sci USA 98(16):9110\u20139115","journal-title":"Proc Natl Acad Sci USA"},{"issue":"25\u201326","key":"5373_CR36","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1016\/j.febslet.2008.10.001","volume":"582","author":"H Karube","year":"2008","unstructured":"Karube H, Sakamoto M, Arawaka S, Hara S, Sato H, Ren CH et al (2008) N-terminal region of alpha-synuclein is essential for the fatty acid-induced oligomerization of the molecules. FEBS Lett 582(25\u201326):3693\u20133700","journal-title":"FEBS Lett"},{"issue":"5","key":"5373_CR37","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.molcel.2018.11.028","volume":"73","author":"S Fanning","year":"2019","unstructured":"Fanning S, Haque A, Imberdis T, Baru V, Barrasa MI, Nuber S et al (2019) Lipidomic analysis of \u03b1-synuclein neurotoxicity identifies stearoyl CoA desaturase as a target for Parkinson treatment. Mol Cell 73(5):1001-1014.e8","journal-title":"Mol Cell"},{"issue":"5651","key":"5373_CR38","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1126\/science.1090439","volume":"302","author":"TF Outeiro","year":"2003","unstructured":"Outeiro TF, Lindquist S (2003) Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 302(5651):1772\u20131775","journal-title":"Science"},{"issue":"11","key":"5373_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009921","volume":"17","author":"V Girard","year":"2021","unstructured":"Girard V, Jollivet F, Knittelfelder O, Celle M, Arsac JN, Chatelain G et al (2021) Abnormal accumulation of lipid droplets in neurons induces the conversion of alpha-Synuclein to proteolytic resistant forms in a Drosophila model of Parkinson\u2019s disease. PLoS Genet 17(11):e1009921","journal-title":"PLoS Genet"},{"issue":"5","key":"5373_CR40","first-page":"773","volume":"32","author":"LJ Smith","year":"2023","unstructured":"Smith LJ, Bolsinger MM, Chau KY, Gegg ME, Schapira AHV (2023) The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell lines. Hum Mol Genet 32(5):773\u2013789","journal-title":"Hum Mol Genet"},{"issue":"44","key":"5373_CR41","doi-asserted-by":"publisher","first-page":"27646","DOI":"10.1073\/pnas.2003021117","volume":"117","author":"OR Brekk","year":"2020","unstructured":"Brekk OR, Honey JR, Lee S, Hallett PJ, Isacson O (2020) Cell type-specific lipid storage changes in Parkinson\u2019s disease patient brains are recapitulated by experimental glycolipid disturbance. Proc Natl Acad Sci U S A 117(44):27646\u201327654","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5373_CR42","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.cell.2014.03.012","volume":"157","author":"RM Evans","year":"2014","unstructured":"Evans RM, Mangelsdorf DJ (2014) Nuclear receptors, RXR, and the big bang. Cell 157(1):255\u2013266","journal-title":"Cell"},{"key":"5373_CR43","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-pharmtox-010818-021807","volume":"59","author":"M Moutinho","year":"2019","unstructured":"Moutinho M, Codocedo JF, Puntambekar SS, Landreth GE (2019) Nuclear receptors as therapeutic targets for neurodegenerative diseases: lost in translation. Annu Rev Pharmacol Toxicol 59:237\u2013261","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4","key":"5373_CR44","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1007\/s12035-021-02709-y","volume":"59","author":"S Sharma","year":"2022","unstructured":"Sharma S, Shen T, Chitranshi N, Gupta V, Basavarajappa D, Sarkar S et al (2022) Retinoid X receptor: cellular and biochemical roles of nuclear receptor with a focus on neuropathological involvement. Mol Neurobiol 59(4):2027\u20132050","journal-title":"Mol Neurobiol"},{"issue":"14","key":"5373_CR45","doi-asserted-by":"publisher","first-page":"9592","DOI":"10.1021\/acs.jmedchem.1c00186","volume":"64","author":"S Willems","year":"2021","unstructured":"Willems S, Zaienne D, Merk D (2021) Targeting nuclear receptors in neurodegeneration and neuroinflammation. J Med Chem 64(14):9592\u20139638","journal-title":"J Med Chem"},{"issue":"6","key":"5373_CR46","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1056\/NEJMra043590","volume":"353","author":"AI Shulman","year":"2005","unstructured":"Shulman AI, Mangelsdorf DJ (2005) Retinoid x receptor heterodimers in the metabolic syndrome. N Engl J Med 353(6):604\u2013615","journal-title":"N Engl J Med"},{"issue":"1","key":"5373_CR47","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbalip.2011.04.003","volume":"1821","author":"E P\u00e9rez","year":"2012","unstructured":"P\u00e9rez E, Bourguet W, Gronemeyer H, de Lera AR (2012) Modulation of RXR function through ligand design. Biochim Biophys Acta 1821(1):57\u201369","journal-title":"Biochim Biophys Acta"},{"issue":"6075","key":"5373_CR48","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1126\/science.1217697","volume":"335","author":"PE Cramer","year":"2012","unstructured":"Cramer PE, Cirrito JR, Wesson DW, Lee CYD, Karlo JC, Zinn AE et al (2012) ApoE-directed therapeutics rapidly clear \u03b2-amyloid and reverse deficits in AD mouse models. Science 335(6075):1503\u20131506","journal-title":"Science"},{"issue":"1","key":"5373_CR49","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s11418-018-1257-z","volume":"73","author":"W Wang","year":"2019","unstructured":"Wang W, Nakashima KI, Hirai T, Inoue M (2019) Neuroprotective effect of naturally occurring RXR agonists isolated from Sophora tonkinensis Gagnep on amyloid-\u03b2-induced cytotoxicity in PC12 cells. J Nat Med. 73(1):154\u201362","journal-title":"J Nat Med."},{"issue":"1","key":"5373_CR50","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.bbadis.2018.10.028","volume":"1865","author":"C Yuan","year":"2019","unstructured":"Yuan C, Guo X, Zhou Q, Du F, Jiang W, Zhou X et al (2019) OAB-14, a bexarotene derivative, improves Alzheimer\u2019s disease-related pathologies and cognitive impairments by increasing \u03b2-amyloid clearance in APP\/PS1 mice. Biochim Biophys Acta Mol Basis Dis 1865(1):161\u2013180","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"5373_CR51","doi-asserted-by":"crossref","unstructured":"Dickey AS, Sanchez DN, Arreola M, Sampat KR, Fan W, Arbez N, et al (2017) PPAR\u03b4 activation by bexarotene promotes neuroprotection by restoring bioenergetic and quality control homeostasis. Sci Transl Med 9(419):eaal2332","DOI":"10.1126\/scitranslmed.aal2332"},{"key":"5373_CR52","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3389\/fncel.2015.00250","volume":"9","author":"J Riancho","year":"2015","unstructured":"Riancho J, Ruiz-Soto M, Berciano MT, Berciano J, Lafarga M (2015) Neuroprotective effect of bexarotene in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Front Cell Neurosci 9:250","journal-title":"Front Cell Neurosci"},{"issue":"11","key":"5373_CR53","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1021\/cn400100f","volume":"4","author":"K McFarland","year":"2013","unstructured":"McFarland K, Spalding TA, Hubbard D, Ma JN, Olsson R, Burstein ES (2013) Low dose bexarotene treatment rescues dopamine neurons and restores behavioral function in models of Parkinson\u2019s disease. ACS Chem Neurosci 4(11):1430\u20131438","journal-title":"ACS Chem Neurosci"},{"key":"5373_CR54","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1471-2202-10-146","volume":"10","author":"S Friling","year":"2009","unstructured":"Friling S, Bergsland M, Kjellander S (2009) Activation of retinoid X receptor increases dopamine cell survival in models for Parkinson\u2019s disease. BMC Neurosci 10:146","journal-title":"BMC Neurosci"},{"issue":"15","key":"5373_CR55","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1073\/pnas.1616874114","volume":"114","author":"AD Spathis","year":"2017","unstructured":"Spathis AD, Asvos X, Ziavra D, Karampelas T, Topouzis S, Cournia Z et al (2017) Nurr1:RXR\u03b1 heterodimer activation as monotherapy for Parkinson\u2019s disease. Proc Natl Acad Sci U S A 114(15):3999\u20134004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"5373_CR56","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1523\/JNEUROSCI.1881-21.2022","volume":"42","author":"A Tripathi","year":"2022","unstructured":"Tripathi A, Alnakhala H, Terry-Kantor E, Newman A, Liu L, Imberdis T et al (2022) Pathogenic mechanisms of cytosolic and membrane-enriched \u03b1-synuclein converge on fatty acid homeostasis. J Neurosci Off J Soc Neurosci 42(10):2116\u20132130","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"31","key":"5373_CR57","doi-asserted-by":"publisher","first-page":"9596","DOI":"10.1073\/pnas.1505953112","volume":"112","author":"U Dettmer","year":"2015","unstructured":"Dettmer U, Newman AJ, von Saucken VE, Bartels T, Selkoe D (2015) KTKEGV repeat motifs are key mediators of normal \u03b1-synuclein tetramerization: Their mutation causes excess monomers and neurotoxicity. Proc Natl Acad Sci USA 112(31):9596\u20139601","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"5373_CR58","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/ejn.14286","volume":"49","author":"Y Chen","year":"2019","unstructured":"Chen Y, Dolt KS, Kriek M, Baker T, Downey P, Drummond NJ et al (2019) Engineering synucleinopathy-resistant human dopaminergic neurons by CRISPR-mediated deletion of the SNCA gene. Eur J Neurosci 49(4):510\u2013524","journal-title":"Eur J Neurosci"},{"issue":"5","key":"5373_CR59","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","volume":"78","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Pak C, Han Y, Ahlenius H, Zhang Z, Chanda S et al (2013) Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78(5):785\u2013798","journal-title":"Neuron"},{"issue":"7359","key":"5373_CR60","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature10202","volume":"476","author":"ZP Pang","year":"2011","unstructured":"Pang ZP, Yang N, Vierbuchen T, Ostermeier A, Fuentes DR, Yang TQ et al (2011) Induction of human neuronal cells by defined transcription factors. Nature 476(7359):220\u2013223","journal-title":"Nature"},{"key":"5373_CR61","unstructured":"TARGRETIN (bexarotene) capsules, for oral use Initial U.S. Approval: 1999\u2019. 2015. Food and Drug Administration, Accessed 26 September 2023. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/021055s010lbl.pdf."},{"issue":"1","key":"5373_CR62","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.expneurol.2011.04.009","volume":"230","author":"H Zhang","year":"2011","unstructured":"Zhang H, Jarjour AA, Boyd A, Williams A (2011) Central nervous system remyelination in culture\u2013a tool for multiple sclerosis research. Exp Neurol 230(1):138\u2013148","journal-title":"Exp Neurol"},{"issue":"8","key":"5373_CR63","first-page":"1360","volume":"15","author":"RM Cesario","year":"2001","unstructured":"Cesario RM, Klausing K, Razzaghi H, Crombie D, Rungta D, Heyman RA et al (2001) The rexinoid LG100754 is a novel RXR:PPARgamma agonist and decreases glucose levels in vivo. Mol Endocrinol Baltim Md 15(8):1360\u20131369","journal-title":"Mol Endocrinol Baltim Md"},{"issue":"4","key":"5373_CR64","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jsbmb.2004.11.007","volume":"94","author":"T Kanayasu-Toyoda","year":"2005","unstructured":"Kanayasu-Toyoda T, Fujino T, Oshizawa T, Suzuki T, Nishimaki-Mogami T, Sato Y et al (2005) HX531, a retinoid X receptor antagonist, inhibited the 9-cis retinoic acid-induced binding with steroid receptor coactivator-1 as detected by surface plasmon resonance. J Steroid Biochem Mol Biol 94(4):303\u2013309","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"8","key":"5373_CR65","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.bbadis.2011.02.014","volume":"1812","author":"T Varga","year":"2011","unstructured":"Varga T, Czimmerer Z, Nagy L (2011) PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation. Biochim Biophys Acta 1812(8):1007\u20131022","journal-title":"Biochim Biophys Acta"},{"key":"5373_CR66","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41531-017-0015-3","volume":"3","author":"CJHM Klemann","year":"2017","unstructured":"Klemann CJHM, Martens GJM, Sharma M, Martens MB, Isacson O, Gasser T et al (2017) Integrated molecular landscape of Parkinson\u2019s disease. NPJ Park Dis 3:14","journal-title":"NPJ Park Dis"},{"key":"5373_CR67","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3389\/fnins.2019.00328","volume":"13","author":"I Alecu","year":"2019","unstructured":"Alecu I, Bennett SAL (2019) Dysregulated lipid metabolism and its role in \u03b1-synucleinopathy in Parkinson\u2019s disease. Front Neurosci 13:328","journal-title":"Front Neurosci"},{"issue":"3","key":"5373_CR68","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41580-018-0085-z","volume":"20","author":"JA Olzmann","year":"2019","unstructured":"Olzmann JA, Carvalho P (2019) Dynamics and functions of lipid droplets. Nat Rev Mol Cell Biol 20(3):137\u2013155","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"5373_CR69","doi-asserted-by":"publisher","first-page":"912","DOI":"10.3390\/biom13060912","volume":"13","author":"N Bresgen","year":"2023","unstructured":"Bresgen N, Kovacs M, Lahnsteiner A, Felder TK, Rinnerthaler M (2023) The janus-faced role of lipid droplets in aging: insights from the cellular perspective. Biomolecules 13(6):912","journal-title":"Biomolecules"},{"issue":"18","key":"5373_CR70","doi-asserted-by":"publisher","first-page":"9443","DOI":"10.1073\/pnas.93.18.9443","volume":"93","author":"CW Miller","year":"1996","unstructured":"Miller CW, Ntambi JM (1996) Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression. Proc Natl Acad Sci U S A 93(18):9443\u20139448","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"31","key":"5373_CR71","doi-asserted-by":"publisher","first-page":"28744","DOI":"10.1074\/jbc.M103587200","volume":"276","author":"W Samuel","year":"2001","unstructured":"Samuel W, Kutty RK, Nagineni S, Gordon JS, Prouty SM, Chandraratna RA et al (2001) Regulation of stearoyl coenzyme A desaturase expression in human retinal pigment epithelial cells by retinoic acid. J Biol Chem 276(31):28744\u201328750","journal-title":"J Biol Chem"},{"key":"5373_CR72","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/607524","volume":"2013","author":"M Darabi","year":"2013","unstructured":"Darabi M, Byagowi S, Fayezi S, Darabi M, Mirshahvaladi S, Sahmani M (2013) Transcriptional regulation of \u03946-desaturase by peroxisome proliferative-activated receptor \u03b4 agonist in human pancreatic cancer cells: role of MEK\/ERK1\/2 pathway. ScientificWorldJournal 2013:607524","journal-title":"ScientificWorldJournal"},{"issue":"7","key":"5373_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2022.159160","volume":"1867","author":"C Wang","year":"2022","unstructured":"Wang C, MacIntyre B, Mutch DM (2022) Inhibition of \u0394-6 desaturase reduces fatty acid re-esterification in 3T3-L1 adipocytes independent of changes in n3-PUFA cellular content. Biochim Biophys Acta Mol Cell Biol Lipids 1867(7):159160","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"9","key":"5373_CR74","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1194\/jlr.M039669","volume":"54","author":"X Shi","year":"2013","unstructured":"Shi X, Li J, Zou X, Greggain J, R\u00f8dk\u00e6r SV, F\u00e6rgeman NJ et al (2013) Regulation of lipid droplet size and phospholipid composition by stearoyl-CoA desaturase. J Lipid Res 54(9):2504\u20132514","journal-title":"J Lipid Res"},{"issue":"Pt 1","key":"5373_CR75","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1042\/bj3400255","volume":"340","author":"L Zhang","year":"1999","unstructured":"Zhang L, Ge L, Parimoo S, Stenn K, Prouty SM (1999) Human stearoyl-CoA desaturase: alternative transcripts generated from a single gene by usage of tandem polyadenylation sites. Biochem J. 340(Pt 1):255\u201364","journal-title":"Biochem J."},{"issue":"3","key":"5373_CR76","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.bbrc.2005.05.013","volume":"332","author":"J Wang","year":"2005","unstructured":"Wang J, Yu L, Schmidt RE, Su C, Huang X, Gould K et al (2005) Characterization of HSCD5, a novel human stearoyl-CoA desaturase unique to primates. Biochem Biophys Res Commun 332(3):735\u2013742","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"5373_CR77","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.202100308","volume":"23","author":"J Rodencal","year":"2023","unstructured":"Rodencal J, Dixon SJ (2023) A tale of two lipids: Lipid unsaturation commands ferroptosis sensitivity. Proteomics 23(6):e2100308","journal-title":"Proteomics"},{"issue":"8","key":"5373_CR78","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s12276-023-01077-y","volume":"55","author":"JW Kim","year":"2023","unstructured":"Kim JW, Lee JY, Oh M, Lee EW (2023) An integrated view of lipid metabolism in ferroptosis revisited via lipidomic analysis. Exp Mol Med 55(8):1620\u20131631","journal-title":"Exp Mol Med"},{"issue":"19","key":"5373_CR79","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.1016\/j.bmcl.2008.08.091","volume":"18","author":"EJ Hanan","year":"2008","unstructured":"Hanan EJ, Fucini RV, Romanowski MJ, Elling RA, Lew W, Purkey HE et al (2008) Design and synthesis of 2-amino-isoxazolopyridines as Polo-like kinase inhibitors. Bioorg Med Chem Lett 18(19):5186\u20135189","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"5373_CR80","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1074\/jbc.C800206200","volume":"284","author":"KJ Inglis","year":"2009","unstructured":"Inglis KJ, Chereau D, Brigham EF, Chiou SS, Sch\u00f6bel S, Frigon NL et al (2009) Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system. J Biol Chem 284(5):2598\u20132602","journal-title":"J Biol Chem"},{"issue":"4","key":"5373_CR81","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1074\/jbc.M109.081950","volume":"285","author":"MK Mbefo","year":"2010","unstructured":"Mbefo MK, Paleologou KE, Boucharaba A, Oueslati A, Schell H, Fournier M et al (2010) Phosphorylation of synucleins by members of the Polo-like kinase family. J Biol Chem 285(4):2807\u20132822","journal-title":"J Biol Chem"},{"issue":"6968","key":"5373_CR82","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nature02263","volume":"426","author":"AL Goldberg","year":"2003","unstructured":"Goldberg AL (2003) Protein degradation and protection against misfolded or damaged proteins. Nature 426(6968):895\u2013899","journal-title":"Nature"},{"issue":"11","key":"5373_CR83","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nrm2245","volume":"8","author":"DJ Klionsky","year":"2007","unstructured":"Klionsky DJ (2007) Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 8(11):931\u2013937","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"5373_CR84","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1172\/JCI73937","volume":"125","author":"H Vakifahmetoglu-Norberg","year":"2015","unstructured":"Vakifahmetoglu-Norberg H, Xia H, Yuan J (2015) Pharmacologic agents targeting autophagy. J Clin Invest. 125(1):5\u201313","journal-title":"J Clin Invest."},{"issue":"41","key":"5373_CR85","doi-asserted-by":"publisher","first-page":"E3945","DOI":"10.1073\/pnas.1309991110","volume":"110","author":"A Oueslati","year":"2013","unstructured":"Oueslati A, Schneider BL, Aebischer P, Lashuel HA (2013) Polo-like kinase 2 regulates selective autophagic \u03b1-synuclein clearance and suppresses its toxicity in vivo. Proc Natl Acad Sci U S A 110(41):E3945-3954","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"5373_CR86","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1172\/JCI88892","volume":"127","author":"JC Achermann","year":"2017","unstructured":"Achermann JC, Schwabe J, Fairall L, Chatterjee K (2017) Genetic disorders of nuclear receptors. J Clin Invest 127(4):1181\u20131192","journal-title":"J Clin Invest"},{"issue":"1","key":"5373_CR87","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrd.2016.230","volume":"16","author":"R Santos","year":"2017","unstructured":"Santos R, Ursu O, Gaulton A, Bento AP, Donadi RS, Bologa CG et al (2017) A comprehensive map of molecular drug targets. Nat Rev Drug Discov 16(1):19\u201334","journal-title":"Nat Rev Drug Discov"},{"issue":"35","key":"5373_CR88","doi-asserted-by":"publisher","first-page":"12501","DOI":"10.1073\/pnas.0503132102","volume":"102","author":"M Miyazaki","year":"2005","unstructured":"Miyazaki M, Dobrzyn A, Elias PM, Ntambi JM (2005) Stearoyl-CoA desaturase-2 gene expression is required for lipid synthesis during early skin and liver development. Proc Natl Acad Sci USA 102(35):12501\u201312506","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"5373_CR89","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.molcel.2020.01.014","volume":"77","author":"N Mejhert","year":"2020","unstructured":"Mejhert N, Kuruvilla L, Gabriel KR, Elliott SD, Guie MA, Wang H et al (2020) Partitioning of MLX-family transcription factors to lipid droplets regulates metabolic gene expression. Mol Cell 77(6):1251-1264.e9","journal-title":"Mol Cell"},{"key":"5373_CR90","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/jn\/82.1.19","volume":"82","author":"LA Witting","year":"1964","unstructured":"Witting LA, Horwitt MK (1964) Effect of degree of fatty acid unsaturation in tocopherol deficiency-induced creatinuria. J Nutr 82:19\u201333","journal-title":"J Nutr"},{"issue":"1","key":"5373_CR91","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41531-023-00444-w","volume":"9","author":"N Ramalingam","year":"2023","unstructured":"Ramalingam N, Jin SX, Moors TE, Fonseca-Ornelas L, Shimanaka K, Lei S et al (2023) Dynamic physiological \u03b1-synuclein S129 phosphorylation is driven by neuronal activity. NPJ Park Dis 9(1):4","journal-title":"NPJ Park Dis"},{"issue":"11","key":"5373_CR92","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1093\/hmg\/dds058","volume":"21","author":"V Sancenon","year":"2012","unstructured":"Sancenon V, Lee SA, Patrick C, Griffith J, Paulino A, Outeiro TF et al (2012) Suppression of \u03b1-synuclein toxicity and vesicle trafficking defects by phosphorylation at S129 in yeast depends on genetic context. Hum Mol Genet 21(11):2432\u20132449","journal-title":"Hum Mol Genet"},{"issue":"2","key":"5373_CR93","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1073\/pnas.0711053105","volume":"105","author":"OS Gorbatyuk","year":"2008","unstructured":"Gorbatyuk OS, Li S, Sullivan LF, Chen W, Kondrikova G, Manfredsson FP et al (2008) The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease. Proc Natl Acad Sci USA 105(2):763\u2013768","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"5373_CR94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004302","volume":"10","author":"S Tenreiro","year":"2014","unstructured":"Tenreiro S, Reim\u00e3o-Pinto MM, Antas P, Rino J, Wawrzycka D, Macedo D et al (2014) Phosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of Parkinson\u2019s disease. PLoS Genet 10(5):e1004302","journal-title":"PLoS Genet"},{"key":"5373_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102021","volume":"90","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang P, Jin G, Shi P, Zhao Y, Guo J et al (2023) The novel function of bexarotene for neurological diseases. Ageing Res Rev 90:102021","journal-title":"Ageing Res Rev"},{"issue":"42","key":"5373_CR96","doi-asserted-by":"publisher","first-page":"14370","DOI":"10.1523\/JNEUROSCI.1155-15.2015","volume":"35","author":"N Volakakis","year":"2015","unstructured":"Volakakis N, Tiklova K, Decressac M, Papathanou M, Mattsson B, Gillberg L et al (2015) Nurr1 and retinoid X receptor ligands stimulate ret signaling in dopamine neurons and can alleviate \u03b1-synuclein disrupted gene expression. J Neurosci Off J Soc Neurosci 35(42):14370\u201314385","journal-title":"J Neurosci Off J Soc Neurosci"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-024-05373-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-024-05373-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-024-05373-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T06:31:49Z","timestamp":1724308309000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-024-05373-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["5373"],"URL":"https:\/\/doi.org\/10.1007\/s00018-024-05373-2","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,20]]},"assertion":[{"value":"29 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"D.S. is a director and consultant to Prothena Biosciences. The remaining authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"362"}}